archives - 過去の開催
The 4th - 2017
The 3rd - 2016
The 2nd - 2015
The 1st - 2014

Program - プログラム

DAY1February 2(Fri.)2月2日(金)

* Please note that program details may be subject to change.
* Simultaneous interpretation is available at this conference.

8:00

Doors open
開場

8:30 - 8:35

Opening Remarks
開会挨拶

8:35 - 8:50

Agenda1 - Defining the 5th Conference; Re-recognizing the objectives
議題1 - 第五回会議の意義付け

Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific

8:50 - 9:10

Keynote Speech
基調講演

Dr. Pedro ALONSO
Director, Global Malaria Programme, World Health Organization

9:10 - 10:05

Agenda2-1 - Achievements of TB Consortium and its Future Challenges
議題2-①結核コンソーシアムの成果と課題

Moderator

Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.

Click here for a list of discussers

  • Dr. Shigeru OMI, MD, PhD
    President of JAPAN Community Health care Organization (JCHO)
    Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
  • Kei KATSUNO, MD, MPH
    Senior Director,
    Investment Strategy & Government Relations
    Global Health Innovative Technology Fund (GHIT Fund)
  • Dr. Seiya KATO
    Director, The Research Institute of Tuberculosis
    Japan Anti-Tuberculosis Association
  • Dr. Junko SATO, PhD
    Office Director, Office of International Cooperation,
    Pharmaceuticals and Medical Devices Agency (PMDA)
  • Prof. Nikki SHINDO, MD, PhD
    Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
  • Manabu SUMI, MD, MPH, PhD
    Director, Global Health Policy Division, Ministry of Foreign Affairs
  • Mr. Kaoru TERASHIMA
    Corporate Vice President, Medical System Business Division,
    In Vitro Diagnostics Division, FUJIFILM Corporation
  • Kuniaki MIYAKE M.D.,M.S
    Director, Tuberculosis and Infectious Diseases Control Division,
    Ministry of Health and Labor and Welfare, Japan (“MHLW”)
  • Mr. Keiso YAMASAKI
    Global Project Leader of TB Projects, Pharmaceutical Business Division,Otsuka Pharmaceutical Co., Ltd.
  • Mr. Hiroshi YOSHIDA
    Director, R&D, NIPRO CORPORATION
  • Mr. Kozo WATANABE
    Deputy Director General, and Group Director for Health 2,
    Human Development Department,
    Japan International Cooperation Agency
  • Mr. Hajime WATARI
    Executive Officer, GM, Global Sales & Business Development
    EIKEN Chemical CO.,LTD.
10:15 - 11:10

Agenda2-2 - Overseas P3 Scheme on Ebola; Lessons Learned from Ebola Outbreak
議題2-②エボラ出血熱に関する海外における官民連携

Moderator

Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.

Click here for a list of discussers

  • Dr. Kazunari ASANUMA, MD, PhD
    Assistant Director-General for Health Sciences, Minister’s Secretariat,
    Ministry of Health, Labour and Welfare
  • Dr. Shigeru OMI, MD, PhD
    President of JAPAN Community Health care Organization (JCHO)
    Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
  • Mr. Hiroaki GOTO
    General Manager,
    Molecular Testing Solutions Business Development Dept.
    Canon Medical Systems Corporation
  • Dr. Tatsuya KONDO
    Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)
  • Prof. Kimiyasu SHIRAKI, MD, PhD
    Professor and Chairman Department of Virology, University of Toyama
  • Prof. Nikki SHINDO, MD, PhD
    Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
  • Manabu SUMI, MD, MPH, PhD
    Director, Global Health Policy Division, Ministry of Foreign Affairs
  • Prof. Jiro YASUDA PhD, DVM
    Director, National Research Center for the Control and Prevention of Infectious Diseases (CCPID) & Professor, Institute of Tropical Medicine (NEKKEN), Nagasaki University
11:20 - 12:20

Lunch Session-1 - Japan China Korea PDPs Collaboration in Emerging Infectious Diseases Countermeasures: A Case of SFTS
ランチセッション① 新興感染症に対する日中韓産官学の取り組み
~重症熱性血小板減少症候群(Severe Fever with Thrombocytopenia Syndrome :SFTS)の事例から~

Adjusting

Click here for a list of discussers

  • Masayuki SAIJO , MD, PhD 
    Director, Department of Virology 1, National Institute of Infectious Diseases
  • Dr. Junko SATO, PhD 
    Office Director, Office of International Cooperation,
    Pharmaceuticals and Medical Devices Agency (PMDA)
  • Prof. Dr. Masaki YASUKAWA, MD, PhD
    Professor, Departmnet of Hematology, Clinical Immunology, and Infectious Diseases, Ehime University Graduate School of Medicine
12:30 - 13:25

Agenda2-3 - Achievements of Malaria Consortium and its Future Challenges
議題2-③マラリアコンソーシアムの成果と課題

Moderator

Prof. Kiyoshi KITA
Dean and Professor, School of Tropical Medicine and Global Health, Nagasaki University

Click here for a list of discussers

  • Dr. Kinya UCHIHASHI, PhD
    Vice President, Cell Technology Engineering 1, Sysmex Corporation
  • Dr. Shigeru OMI, MD, PhD
    President of JAPAN Community Health care Organization (JCHO)
    Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
  • Dr. Kaname KANAI, MD, Ph.D.
    Human Development Department / Exective Technical Advisor,
    Japan International Cooperation Agency
  • Prof. Akira KANEKO, MD, PhD, DTM&H
    Professor, Department of Parasitology, Osaka City University Graduate School of Medicine
  • Prof. Dr. Shigeyuki KANO , MD, PhD
    Director, Department of Tropical Medicine and Malaria
    National Center for Global Health and Medicine, Research Institute
  • Mr. Satofumi KAWATA
    Representative Director, neopharma Japan Co., Ltd. 
  • Prof. Nikki SHINDO, MD, PhD
    Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
  • Manabu SUMI, MD, MPH, PhD
    Director, Global Health Policy Division, Ministry of Foreign Affairs
  • Prof. Takafumi TSUBOI, MD, PhD
    Director, Proteo-Science Center, Ehime University
  • Mr. Ray NISHIMOTO
    Representative Director & Senior Managing Executive Officer,
    Sumitomo Chemical Company, Limited
  • Prof. Toshihiro HORII, PhD
    Professor, Research Center for Infectious Disease Control, Research Institute for Microbial Diseases, Osaka University
  • Kuniaki MIYAKE M.D.,M.S
    Director, Tuberculosis and Infectious Diseases Control Division,
    Ministry of Health and Labor and Welfare, Japan (“MHLW”)
  • Mr. Mitsuru MIYATA
    Executive Leader Writer, Nikkei Business Publications, Inc.
  • Assoc. Prof. Pratap SINGHASIVANON, MD.
    Dean, Faculty of Tropical Medicine, Mahidol University
  • Dr. Pedro ALONSO
    Director, Global Malaria Programme, World Health Organization
  • Dr. BT SLINGSBY, MD, PhD, MPH
    CEO & Executive Director
    Global Health Innovative Technology Fund (GHIT Fund)
13:35 - 14:30

Agenda2-4 - Approaches towards AMR
議題2-④薬剤耐性(AMR)への取り組み

Moderator

Dr. Kazunari ASANUMA, MD, PhD
Assistant Director-General for Health Sciences, Minister’s Secretariat,
Ministry of Health, Labour and Welfare

Click here for a list of discussers

  • Dr. Shigeru OMI, MD, PhD
    President of JAPAN Community Health care Organization (JCHO)
    Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
  • Prof. Dr. Shigeyuki KANO , MD, PhD
    Director, Department of Tropical Medicine and Malaria
    National Center for Global Health and Medicine, Research Institute
  • Toru Kimura, Ph.D.
    Member, Board of Directors Executive Officer, Sumitomo Dainippon Pharma Co., Ltd.
  • Mr. Michikazu KOSHIBA
    Head, Center on Global Health Architecture/ Senior Manager, Business Creation Office, Corporate Planning Dept.
    MITSUBISHI UFJ RESEARCH AND CONSULTING CO LTD
  • Dr. Junko SATO, PhD
    Office Director, Office of International Cooperation,
    Pharmaceuticals and Medical Devices Agency (PMDA)
  • Ms. Takuko SAWADA
    Director of the Board, Senior Executive Officer, Senior Vice President, Corporate Strategy Division, Shionogi & Co., Ltd.
  • Mr. Yusuke SARAYA
    President, Saraya Co., Ltd.
  • Prof. Nikki SHINDO, MD, PhD
    Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
  • Mitsuru TODA, MS, PhD
    Epidemic Intelligence Service (EIS) Officer, Mycotic Diseases Branch,
    National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC)
  • Mr. Ryoji NORITAKE
    President, Health and Global Policy Institute;
    Pro-bono Consultant, Project HOPE
  • Director. Dr. Hideaki HANAKI, Ph, PhD
    Director, Infection Control Research Center, Kitasato University
  • Dr. Kazuki HOSHINO, PhD
    R&D Planning & Management Department,
    Kitasato Daiichi Sankyo Vaccine Co., Ltd.
  • Prof. Satoshi MITARAI MD, Ph.D.
    Head, Dept. of Mycobacterium Reference and Research
    Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association
  • Kuniaki MIYAKE M.D.,M.S
    Director, Tuberculosis and Infectious Diseases Control Division,
    Ministry of Health and Labor and Welfare, Japan (“MHLW”)
  • Mr. Mitsuru MIYATA
    Executive Leader Writer, Nikkei Business Publications, Inc.
  • Dr. Yasuhiro YASUTOMI, DVM, PhD
    Director, Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN)
    Professor, Division of Immunoregulation, Department of Molecular and Experimental Medecine, Mie University Graduate School of Medicine
  • Dr. Trinh Hong SON
    Reseacher. Director of Center for Nutrition Information, Education and
    Communication (NIEC), National Institute of Nutrition (NIN)
  • Dr. Peter JACKSON
    Executive Director, The AMR Centre
14:40 - 15:35

Agenda3-1 - Establishment of “Asian Communicable Diseases Clinical Research Center”, and the Role of Okinawa in the Concept
議題3-①アジアにおける感染症臨床試験センターおよび沖縄感染症研究拠点の構築

Moderator①

Dr. Yasuhiro YASUTOMI, DVM, PhD
Director, Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN)
Professor, Division of Immunoregulation, Department of Molecular and Experimental Medecine, Mie University Graduate School of Medicine

Moderator②

Prof. Jiro FUJITA, MD, PhD, FCCP
Director, University of the Ryukyus Hospital

Click here for a list of discussers

  • Tatsuo IIYAMA, M.D.
    Chief manager of the Department of International Trial, Center for Clinical Sciences,
    National Center for Global Health and Medicine (NCGM)
  • Dr. Hitoshi OINUMA, PhD
    Senior Vice President, Head of Japan Vaccine Business Unit, Takeda Pharmaceutical Company Limited
  • Prof. Hitoshi OSHITANI, MD, PhD, MPH
    Professor, Medicine Department of Virology, Tohoku University Graduate School
  • Dr. Shigeru OMI, MD, PhD
    President of JAPAN Community Health care Organization (JCHO)
    Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
  • Prof. Dr. Shigeyuki KANO , MD, PhD
    Director, Department of Tropical Medicine and Malaria
    National Center for Global Health and Medicine, Research Institute
  • Dr. Tatsuya KONDO
    Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)
  • Prof. Kenji SHIBUYA, MD, DrPH
    Professor, Global Health Policy, Graduate School of Medicine,
    University of Tokyo
  • Prof. Nikki SHINDO, MD, PhD
    Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
  • Director. Dr. Hideaki HANAKI, Ph, PhD
    Director, Infection Control Research Center, Kitasato University
  • Kuniaki MIYAKE M.D.,M.S
    Director, Tuberculosis and Infectious Diseases Control Division,
    Ministry of Health and Labor and Welfare, Japan (“MHLW”)
  • Mr. Mitsuru MIYATA
    Executive Leader Writer, Nikkei Business Publications, Inc.
  • Dr. Yoshinori YAMANO, Ph.D.
    Chief Scientific Officer for Infectious Diseases,
    Pharmaceutical Research Division, SHIONOGI & CO., LTD.
  • Mr. Kozo WATANABE
    Deputy Director General, and Group Director for Health 2,
    Human Development Department,
    Japan International Cooperation Agency
  • Prof. Dr. Suchinda MALAIVIJITNOND, Ph.D.
    Professor at Chulalongkorn University, and Director of the National Primate Research Center of Thailand-Chulalongkorn University (NPRCT-CU)
  • Assoc. Prof. Pratap SINGHASIVANON, MD.
    Dean, Faculty of Tropical Medicine, Mahidol University
15:45 - 16:40

Agenda3-2 - Initiatives in the Area of Public Hygiene: Water Infrastructure and Public Hygiene
議題3-②公衆衛生におけるイニシアチブ~水インフラと公衆衛生~

Moderator

Prof. Hitoshi OSHITANI, MD, PhD, MPH
Professor, Medicine Department of Virology,
Tohoku University Graduate School

Click here for a list of discussers

  • Dr. Shigeru OMI, MD, PhD
    President of JAPAN Community Health care Organization (JCHO)
    Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
  • Mr. Michikazu KOSHIBA
    Head, Center on Global Health Architecture/ Senior Manager, Business Creation Office, Corporate Planning Dept.
    MITSUBISHI UFJ RESEARCH AND CONSULTING CO LTD
  • Mr. Yusuke SARAYA
    President, Saraya Co., Ltd.
  • Prof. Nikki SHINDO, MD, PhD
    Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
  • Manabu SUMI, MD, MPH, PhD
    Director, Global Health Policy Division, Ministry of Foreign Affairs
  • Mr. Mitsuru MIYATA
    Executive Leader Writer, Nikkei Business Publications, Inc.
  • Mr. Kozo WATANABE
    Deputy Director General, and Group Director for Health 2,
    Human Development Department,
    Japan International Cooperation Agency
Breakout Session A
分科会A
Breakout Session B
分科会B
Breakout Session C
分科会C
16:50 - 17:45

A-1

Saraya

Hand Hygiene for IPC (Infection Prevention and Control) against AMR(Tentative Proposal) ~Intervention with ABHR to the AMR issues: focus on ESBL producing bacteria in Vietnam~
AMRに立ち向かおう!HAND HYGIENEアプローチの可能性

Moderator

Mr. Michikazu KOSHIBA
Head, Center on Global Health Architecture/ Senior Manager, Business Creation Office, Corporate Planning Dept.
MITSUBISHI UFJ RESEARCH AND CONSULTING CO LTD

Click here for a list of discussers

  • Mr. Yusuke SARAYA
    President, Saraya Co., Ltd.
  • Jun MORIYAMA, RN MSN
    National Center for Global Health and Medicine Bureau of International Health Cooperation
    JICA Project for Improvement of Hospital Management Competency(Patient Safety, Nursing Management)
  • Mr. Kozo WATANABE
    Deputy Director General, and Group Director for Health 2,
    Human Development Department,
    Japan International Cooperation Agency

B-1

SHIONOGI

Issues and Actions to Combat Influenza Virus Infection
インフルエンザウイルス感染症対策の現状と課題

Moderator

Prof. Yoshihiro KAWAOKA DVM, PhD
Department of Microbiology and immunology, Professor
University of Tokyo, Institute of Medical Science

Click here for a list of discussers

  • Mr. Yoshikatsu OBU
    Counsellor
    Office for Pandemic Influenza Preparedness and Response /
    Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat
  • Dr. Akira NAITO, PhD
    Department Head of Infectious Diseases,
    Drug Discovery & Disease Research Laboratory,
    Shionogi & Co. Ltd.
  • Prof. Jiro FUJITA, MD, PhD, FCCP
    Director, University of the Ryukyus Hospital
  • Mr. Hiroshi YOSHIDA
    Director, R&D, NIPRO CORPORATION
  • Vivi LISDAWATI, MSi, Apt., PhD.
    Director of Research on Infectious & Communicable Diseases,
    Sulianti Saroso Infectious Diseases Hospital, MoH – Rep. of Indonesia

C-1

SYSMEX

WHO's goal for Malaria Elimination ~Contribution of new diagnostic technologies~
WHOの目指すマラリアエリミネーション -新たな診断技術の貢献-

Moderator

Prof. Kiyoshi KITA
Dean and Professor, School of Tropical Medicine and Global Health, Nagasaki University

Click here for a list of discussers

  • Dr. Kinya UCHIHASHI, PhD
    Vice President, Cell Technology Engineering 1, Sysmex Corporation
  • Tomomi KITAMURA, MD,
    Deputy director, The Office for Global Strategy of Medical Service and Health Industry, General Affairs Division, Health Policy Bureau
    Ministry of Health, Labour, and Welfare
  • Assoc. Prof. Pratap SINGHASIVANON, MD.
    Dean, Faculty of Tropical Medicine, Mahidol University
17:50 - 18:45

A-2

Okinawa Prefecture

Efforts and prospects towards a center of excellence on communicable diseases research in Okinawa.
沖縄感染症研究拠点形成に向けた取組と展望

Moderator

Prof. Jiro FUJITA, MD, PhD, FCCP
Director, University of the Ryukyus Hospital

Click here for a list of discussers

  • Mr. Noboru KAKAZU
    Department of Planning/Deputy Director General in charge of Planning Promotion Okinawa Prefectural Government
  • Dr. Tomimasa SUNAGAWA, MD, PhD
    Division Chief / Infectious Disease Surveillance Center National Institute of Infectious Diseases, Japan
  • Dr. Yoshihiro TAKAYAMA , MD
    Division of Infectious Diseases / chief physician
    Okinawa Chubu Hospital
  • Mr. Munesada YAMAKAWA
    Department of Public Health and Medical Care ,
    Regional Public Health Division / Director
    Okinawa Prefectural Government
  • Professor Tetsu YAMASHIRO, MD., PhD
    Department of Bacteriology, Professor
    Graduate School of Medicine, University of the Ryukyus

B-2

DAIICHI SANKYO

Unmet needs in prevention and treatment of infectious diseases in Asian countries and sustainable contribution by industries
アジアにおける感染症予防薬・治療薬のニーズと企業による貢献

Moderator

Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.

Click here for a list of discussers

  • Dr. Kazunari ASANUMA, MD, PhD
    Assistant Director-General for Health Sciences, Minister’s Secretariat,
    Ministry of Health, Labour and Welfare
  • Norihito UEDA, MD, PhD
    Vice President, Vaccine Oversight Department,
    Daiichi Sankyo Co., Ltd.
  • Mr. Takato KOIZUMI
    Deputy Counsellor
    Office for Pandemic Influenza Preparedness and Response, Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat
  • Dr. Junko SATO, PhD
    Office Director, Office of International Cooperation,
    Pharmaceuticals and Medical Devices Agency (PMDA)
  • Prof. Dr. Suchinda MALAIVIJITNOND, Ph.D.
    Professor at Chulalongkorn University, and Director of the National Primate Research Center of Thailand-Chulalongkorn University (NPRCT-CU)
  • Dr. Jean-Pierre PACCAUD, PhD
    Director of Business Development and Corporate Strategy,
    Global Antibiotic R&D Partnership (GARDP)

C-2

Sumitomo Chemical

Vector Control - current status and challenges in Asia and Africa
アジア、アフリカにおけるベクターコントロールの現状と課題

Moderator

Prof. Noboru MINAKAWA PhD
Professor, Institute of Tropical Medicine, Nagasaki University

Click here for a list of discussers

  • Mr. Ray NISHIMOTO
    Representative Director & Senior Managing Executive Officer,
    Sumitomo Chemical Company, Limited
  • Mr. Tatsuo MIZUNO
    Executive Director, Malaria No More Japan
  • Dr. Pedro ALONSO
    Director, Global Malaria Programme, World Health Organization
  • Mr. Patrik SILBORN
    Senior Director Resource Mobilization
    Asia Pacific Leaders Malaria Alliance (APLMA)

DAY2February 3(Sat.)2月3日(土)

* Please note that program details may be subject to change.
* Simultaneous interpretation is available at this conference.

8:00

Doors open
開場

8:30 - 8:50

Keynote Session: UNITAID and FT
基調対談:UNITAID and FT

Vincent BRETIN, PhD
Director, Results, Unitaid

Mr. Victor MALLET

8:50 - 9:45

Agenda3-3 - Procurement and Logistics in Communicable Diseases Countermeasures
議題3-③感染症対策における調達と物流~必要な人にどう届けるか~

Moderator

Mr. Yasuhide YAMADA
Former Director-General of Coordination Office of Measures on Emerging Infectious Diseases and Office for Pandemic Influenza Preparedness and Response, Cabinet Secretariat

Click here for a list of discussers

  • Dr. Shigeru OMI, MD, PhD
    President of JAPAN Community Health care Organization (JCHO)
    Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
  • Prof. Osamu Kunii, MD, MPH, PhD,
    Head, Strategy, Investment and Impact Division,The Global Fund to Fight AIDS, Tuberculosis and Malaria
  • Prof. Nikki SHINDO, MD, PhD
    Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
  • Manabu SUMI, MD, MPH, PhD
    Director, Global Health Policy Division, Ministry of Foreign Affairs
  • Kuniaki MIYAKE M.D.,M.S
    Director, Tuberculosis and Infectious Diseases Control Division,
    Ministry of Health and Labor and Welfare, Japan (“MHLW”)
  • Mr. Mitsuru MIYATA
    Executive Leader Writer, Nikkei Business Publications, Inc.
  • Prof. Jiro YASUDA PhD, DVM
    Director, National Research Center for the Control and Prevention of Infectious Diseases (CCPID) & Professor, Institute of Tropical Medicine (NEKKEN), Nagasaki University
  • Mr. Pankaj GARG
    Founder / CEO
    I.T.E CO.Ltd(Innovation thru Energy Co.Ltd)
9:50 - 10:45

Agenda3-4 - Utilizing IT and AI in the Area of Communicable Diseases Countermeasures
議題3-④感染症対策におけるIT・AIの活用

Moderator

Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.

Click here for a list of discussers

  • Dr. Kazunari ASANUMA, MD, PhD
    Assistant Director-General for Health Sciences, Minister’s Secretariat,
    Ministry of Health, Labour and Welfare
  • Dr. Shigeru OMI, MD, PhD
    President of JAPAN Community Health care Organization (JCHO)
    Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
  • Prof. Osamu Kunii, MD, MPH, PhD,
    Head, Strategy, Investment and Impact Division,The Global Fund to Fight AIDS, Tuberculosis and Malaria
  • Dr. Tatsuya KONDO
    Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)
  • Prof. Nikki SHINDO, MD, PhD
    Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
  • Mitsuru TODA, MS, PhD
    Epidemic Intelligence Service (EIS) Officer, Mycotic Diseases Branch,
    National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC)
  • Kuniaki MIYAKE M.D.,M.S
    Director, Tuberculosis and Infectious Diseases Control Division,
    Ministry of Health and Labor and Welfare, Japan (“MHLW”)
  • Mr. Kozo WATANABE
    Deputy Director General, and Group Director for Health 2,
    Human Development Department,
    Japan International Cooperation Agency
10:50 - 11:40

Summary Session
サマリーセッション

Moderator

Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO)
Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific

Click here for a list of discussers

  • Dr. Kazunari ASANUMA, MD, PhD
    Assistant Director-General for Health Sciences, Minister’s Secretariat,
    Ministry of Health, Labour and Welfare
  • Norihito UEDA, MD, PhD
    Vice President, Vaccine Oversight Department,
    Daiichi Sankyo Co., Ltd.
  • Prof. Hitoshi OSHITANI, MD, PhD, MPH
    Professor, Medicine Department of Virology, Tohoku University Graduate School
  • Prof. Kiyoshi KITA
    Dean and Professor, School of Tropical Medicine and Global Health, Nagasaki University
  • Prof. Osamu Kunii, MD, MPH, PhD,
    Head, Strategy, Investment and Impact Division,The Global Fund to Fight AIDS, Tuberculosis and Malaria
  • Mr. Michikazu KOSHIBA
    Head, Center on Global Health Architecture/ Senior Manager, Business Creation Office, Corporate Planning Dept.
    MITSUBISHI UFJ RESEARCH AND CONSULTING CO LTD
  • Prof. Nikki SHINDO, MD, PhD
    Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
  • Prof. Jiro FUJITA, MD, PhD, FCCP
    Director, University of the Ryukyus Hospital
  • Prof. Noboru MINAKAWA PhD
    Professor, Institute of Tropical Medicine, Nagasaki University
  • Mr. Mitsuru MIYATA
    Executive Leader Writer, Nikkei Business Publications, Inc.
  • Dr. Yasuhiro YASUTOMI, DVM, PhD
    Director, Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN)
    Professor, Division of Immunoregulation, Department of Molecular and Experimental Medecine, Mie University Graduate School of Medicine
  • Dr. Yoshinori YAMANO, Ph.D.
    Chief Scientific Officer for Infectious Diseases,
    Pharmaceutical Research Division, SHIONOGI & CO., LTD.
11:45 - 12:45

Lunch Session-2 - Japan's Challenges against Emerging Infectious Diseases : Establishing Platform towards Exceptional Application of Treatment Drugs and Vacccines at Trial Stages during Pandemics
ランチセッション② 新興・再興感染症に対して日本が目指すべき対応とは?
          ~開発中の治療薬・ワクチンの活用に関するプラットフォーム構築へ向けて

Adjusting

Click here for a list of discussers

  • Mr. Satofumi KAWATA
    Representative Director, neopharma Japan Co., Ltd.
  • Dr. Junko SATO, PhD 
    Office Director, Office of International Cooperation,
    Pharmaceuticals and Medical Devices Agency (PMDA)
  • Eiichi YAMAGUCHI, Ph.D.
    Executive member, International Affairs Committee
    Japan Pharmaceutical Manufacturers Association
12:55 - 13:50

Technology Showcase
テクノロジーショーケース

Moderator

Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.

Click here for a list of discussers

  • Dr. Shigeru OMI, MD, PhD
    President of JAPAN Community Health care Organization (JCHO)
    Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
  • Mr. Akihiko KANAMOTO
    President & CEO
    OP Bio Factory Co., Ltd.
  • Prof. Osamu Kunii, MD, MPH, PhD,
    Head, Strategy, Investment and Impact Division,The Global Fund to Fight AIDS, Tuberculosis and Malaria
  • Prof. Nikki SHINDO, MD, PhD
    Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
  • Mr. Hisato DOI
    President, Representative Director, EVEC, Inc.
  • Dr. Hiromi YATSUDA
    General Manager, Biosensor Project, Research and Development, Japan Radio Co., Ltd.
  • Dr. Katsuhisa YAMAZAKI , PhD
    Department head of Intellectual Property and Public Relations, Institute of Microbial Chemistry,
    Microbial Chemistry Research Foundation (BIKAKEN)
  • Dr. Kazuo YAMASHITA
    CEO, KOTAI Biotechnologies, Inc.
  • Vincent BRETIN, PhD
    Director, Results, Unitaid
  • Dr. Gary DUBIN, MD
    Senior Vice President and Head, Global Medical Office, Vaccine Business Unit, Takeda Pharmaceuticals Company Limited
  • Dr. BT SLINGSBY, MD, PhD, MPH
    CEO & Executive Director
    Global Health Innovative Technology Fund (GHIT Fund)
13:55 - 14:20

Conclusion
ステートメント策定

Moderator

Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific

Click here for a list of discussers

  • Dr. Kazunari ASANUMA, MD, PhD
    Assistant Director-General for Health Sciences, Minister’s Secretariat,
    Ministry of Health, Labour and Welfare
  • Prof. Hitoshi OSHITANI, MD, PhD, MPH
    Professor, Medicine Department of Virology, Tohoku University Graduate School
  • Prof. Kiyoshi KITA
    Dean and Professor, School of Tropical Medicine and Global Health, Nagasaki University
  • Dr. Kiyoshi KUROKAWA
    Professor Emeritus, National Graduate Institute for Policy Studies
    Chairman, Health and Global Policy Institute
    Chair and Representative Director, Global Health Innovative Technology Fund (GHIT Fund)
  • Prof. Nikki SHINDO, MD, PhD
    Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
  • Prof. Jiro FUJITA, MD, PhD, FCCP
    Director, University of the Ryukyus Hospital
  • Mr. Mitsuru MIYATA
    Executive Leader Writer, Nikkei Business Publications, Inc.
  • Dr. Yasuhiro YASUTOMI, DVM, PhD
    Director, Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN)
    Professor, Division of Immunoregulation, Department of Molecular and Experimental Medecine, Mie University Graduate School of Medicine
14:20 - 14:30

General Overview
総評

Prof. Keizo TAKEMI
Member of the House of Councillors,
Chairman of Special Mission Committee on Global Health of LDP
Chairman, LDP Policy Board in the House of Councillors
Senior Fellow, Japan Center for International Exchange (JCIE)
Visiting Professor at Nagasaki University
Visiting Professor at School of Medicine, Keio University

Seminar Registration - セミナー申し込み

Register - 参加申し込み

Press the button to go to the register form provided by EventRegist Co. Ltd.
The contact information to the organizer will be in the register form.

参加申し込みボタンを押すとイベントレジスト内の登録フォームに移動します。
主催者への問合せ先は登録フォーム内にございます。

nikkei 日経BP社 日経メディカル開発ロゴ 沖縄県

Sponsors with lunch / breakout session

富士フィルム 富山化学工業 ネオファーマジャパン
第一三共 サラヤ 塩野義製薬 住友化学 シスメックス

Sponsors

Eiken chemical co.,ltd. Global Health Innovative Technology Fund (GHIT Fund) Mitsubishi Tanabe Pharma Corporation
 NIPRO CORPORATIONTakeda Pharmaceutical Company Limited
Sumitomo Dainippon Pharma Co., Ltd.UNITAID

topへ戻る